Clearside Biomedical
CLSD
$1.34
Share price
6.35%
Change (1 day)
31.37%
Change (1 year)
Categories
Operating Margin for Clearside Biomedical (CLSD)
Operating Margin as of April 2024 (TTM): -2,233.15%
According to Clearside Biomedical 's latest financial reports and stock price the company's current Operating Margin is -2,233.15%. At the end of 2021 the company had an Operating Margin of 1.27%.
Operating Margin history for Clearside Biomedical from 2016 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 1.27% | -100.55% |
| 2020 | -230.68% | -83.71% |
| 2019 | -1,416.01% | -99.49% |
| 2018 | -276,060.00% | 1514.93% |
| 2017 | -17,094.20% | 243.44% |
| 2016 | -4,977.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.